Ebola RNA persistence in semen of ebola virus disease survivors — Final report

G. F. Deen, N. Broutet, W. Xu, B. Knust, F. R. Sesay, S. L.R. McDonald, E. Ervin, J. E. Marrinan, P. Gaillard, N. Habib, H. Liu, W. Liu, A. E. Thorson, F. Yamba, T. A. Massaquoi, F. James, A. Ariyarajah, C. Ross, K. Bernstein, A. CoursierJ. Klena, M. Carino, A. H. Wurie, Y. Zhang, M. S. Dumbuya, N. Abad, B. Idriss, T. Wi, S. D. Bennett, T. Davies, F. K. Ebrahim, E. Meites, D. Naidoo, S. J. Smith, P. Ongpin, T. Malik, A. Banerjee, B. R. Erickson, Y. Liu, Y. Liu, K. Xu, Aaron Brault, K. N. Durski, J. Winter, T. Sealy, S. T. Nichol, M. Lamunu, J. Bangura, S. Landoulsi, A. Jambai, O. Morgan, G. Wu, M. Liang, Q. Su, Y. Lan, Y. Hao, P. Formenty, U. Ströher, F. Sahr

Research output: Contribution to journalArticle

178 Scopus citations

Abstract

BACKGROUND: Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD). We report the presence of Ebola virus RNA in semen in a cohort of survivors of EVD in Sierra Leone. METHODS: We enrolled a convenience sample of 220 adult male survivors of EVD in Sierra Leone, at various times after discharge from an Ebola treatment unit (ETU), in two phases (100 participants were in phase 1, and 120 in phase 2). Semen specimens obtained at baseline were tested by means of a quantitative reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay with the use of the target sequences of NP and VP40 (in phase 1) or NP and GP (in phase 2). This study did not evaluate directly the risk of sexual transmission of EVD. RESULTS: Of 210 participants who provided an initial semen specimen for analysis, 57 (27%) had positive results on quantitative RT-PCR. Ebola virus RNA was detected in the semen of all 7 men with a specimen obtained within 3 months after ETU discharge, in 26 of 42 (62%) with a specimen obtained at 4 to 6 months, in 15 of 60 (25%) with a specimen obtained at 7 to 9 months, in 4 of 26 (15%) with a specimen obtained at 10 to 12 months, in 4 of 38 (11%) with a specimen obtained at 13 to 15 months, in 1 of 25 (4%) with a specimen obtained at 16 to 18 months, and in no men with a specimen obtained at 19 months or later. Among the 46 participants with a positive result in phase 1, the median baseline cycle-threshold values (higher values indicate lower RNA values) for the NP and VP40 targets were lower within 3 months after ETU discharge (32.4 and 31.3, respectively; in 7 men) than at 4 to 6 months (34.3 and 33.1; in 25), at 7 to 9 months (37.4 and 36.6; in 13), and at 10 to 12 months (37.7 and 36.9; in 1). In phase 2, a total of 11 participants had positive results for NP and GP targets (samples obtained at 4.1 to 15.7 months after ETU discharge); cycle-threshold values ranged from 32.7 to 38.0 for NP and from 31.1 to 37.7 for GP. CONCLUSIONS: These data showed the long-term presence of Ebola virus RNA in semen and declining persistence with increasing time after ETU discharge.

Original languageEnglish (US)
Pages (from-to)1428-1437
Number of pages10
JournalNew England Journal of Medicine
Volume377
Issue number15
DOIs
StatePublished - Oct 12 2017
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Ebola RNA persistence in semen of ebola virus disease survivors — Final report'. Together they form a unique fingerprint.

  • Cite this

    Deen, G. F., Broutet, N., Xu, W., Knust, B., Sesay, F. R., McDonald, S. L. R., Ervin, E., Marrinan, J. E., Gaillard, P., Habib, N., Liu, H., Liu, W., Thorson, A. E., Yamba, F., Massaquoi, T. A., James, F., Ariyarajah, A., Ross, C., Bernstein, K., ... Sahr, F. (2017). Ebola RNA persistence in semen of ebola virus disease survivors — Final report. New England Journal of Medicine, 377(15), 1428-1437. https://doi.org/10.1056/NEJMoa1511410